rs27713

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001999.4(FBN2):​c.5675-9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.698 in 1,572,472 control chromosomes in the GnomAD database, including 381,980 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.69 ( 34471 hom., cov: 31)
Exomes 𝑓: 0.70 ( 347509 hom. )

Consequence

FBN2
NM_001999.4 intron

Scores

2
Splicing: ADA: 0.00001468
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 0.918

Publications

7 publications found
Variant links:
Genes affected
FBN2 (HGNC:3604): (fibrillin 2) The protein encoded by this gene is a component of connective tissue microfibrils and may be involved in elastic fiber assembly. Mutations in this gene cause congenital contractural arachnodactyly. [provided by RefSeq, Jul 2008]
FBN2 Gene-Disease associations (from GenCC):
  • congenital contractural arachnodactyly
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • carpal tunnel syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Franklin by Genoox
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • macular degeneration, early-onset
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 5-128305091-G-A is Benign according to our data. Variant chr5-128305091-G-A is described in ClinVar as Benign. ClinVar VariationId is 129043.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.828 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FBN2NM_001999.4 linkc.5675-9C>T intron_variant Intron 44 of 64 ENST00000262464.9 NP_001990.2 P35556-1
FBN2XM_017009228.3 linkc.5522-9C>T intron_variant Intron 43 of 63 XP_016864717.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FBN2ENST00000262464.9 linkc.5675-9C>T intron_variant Intron 44 of 64 1 NM_001999.4 ENSP00000262464.4 P35556-1
FBN2ENST00000703783.1 linkn.2459-9C>T intron_variant Intron 19 of 37
FBN2ENST00000703785.1 linkn.2378-9C>T intron_variant Intron 18 of 26

Frequencies

GnomAD3 genomes
AF:
0.693
AC:
101358
AN:
146238
Hom.:
34438
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.616
Gnomad AMI
AF:
0.625
Gnomad AMR
AF:
0.703
Gnomad ASJ
AF:
0.705
Gnomad EAS
AF:
0.849
Gnomad SAS
AF:
0.754
Gnomad FIN
AF:
0.769
Gnomad MID
AF:
0.758
Gnomad NFE
AF:
0.704
Gnomad OTH
AF:
0.671
GnomAD2 exomes
AF:
0.708
AC:
166381
AN:
235054
AF XY:
0.713
show subpopulations
Gnomad AFR exome
AF:
0.529
Gnomad AMR exome
AF:
0.675
Gnomad ASJ exome
AF:
0.708
Gnomad EAS exome
AF:
0.858
Gnomad FIN exome
AF:
0.767
Gnomad NFE exome
AF:
0.698
Gnomad OTH exome
AF:
0.713
GnomAD4 exome
AF:
0.698
AC:
995491
AN:
1426126
Hom.:
347509
Cov.:
29
AF XY:
0.701
AC XY:
497590
AN XY:
710328
show subpopulations
African (AFR)
AF:
0.611
AC:
17606
AN:
28802
American (AMR)
AF:
0.683
AC:
29219
AN:
42764
Ashkenazi Jewish (ASJ)
AF:
0.715
AC:
18470
AN:
25836
East Asian (EAS)
AF:
0.859
AC:
33677
AN:
39220
South Asian (SAS)
AF:
0.744
AC:
62916
AN:
84524
European-Finnish (FIN)
AF:
0.771
AC:
40797
AN:
52940
Middle Eastern (MID)
AF:
0.732
AC:
4159
AN:
5684
European-Non Finnish (NFE)
AF:
0.688
AC:
748017
AN:
1087482
Other (OTH)
AF:
0.690
AC:
40630
AN:
58874
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
13181
26363
39544
52726
65907
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18990
37980
56970
75960
94950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.693
AC:
101440
AN:
146346
Hom.:
34471
Cov.:
31
AF XY:
0.697
AC XY:
49903
AN XY:
71548
show subpopulations
African (AFR)
AF:
0.617
AC:
22285
AN:
36140
American (AMR)
AF:
0.703
AC:
10587
AN:
15070
Ashkenazi Jewish (ASJ)
AF:
0.705
AC:
2441
AN:
3464
East Asian (EAS)
AF:
0.849
AC:
4374
AN:
5154
South Asian (SAS)
AF:
0.755
AC:
3634
AN:
4814
European-Finnish (FIN)
AF:
0.769
AC:
8092
AN:
10516
Middle Eastern (MID)
AF:
0.753
AC:
220
AN:
292
European-Non Finnish (NFE)
AF:
0.704
AC:
47849
AN:
67924
Other (OTH)
AF:
0.674
AC:
1388
AN:
2060
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1704
3408
5112
6816
8520
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
810
1620
2430
3240
4050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.592
Hom.:
13290
Bravo
AF:
0.651

ClinVar

Significance: Benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 04, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 02, 2012
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Apr 04, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

5675-9C>T in intron 44 of FBN2: This variant is not expected to have clinical si gnificance because it has been identified in 86.5% (173/200) of Han Chinese chro mosomes from a broad population by the 1000 Genomes Project (http://www.ncbi.nlm .nih.gov/projects/SNP; dbSNP rs60746914). -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Congenital contractural arachnodactyly Benign:6
Jul 28, 2017
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2014
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Familial thoracic aortic aneurysm and aortic dissection Benign:1
Aug 15, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Macular degeneration, early-onset Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Nov 27, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.41
DANN
Benign
0.74
PhyloP100
0.92
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000015
dbscSNV1_RF
Benign
0.034
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs27713; hg19: chr5-127640783; API